A biotech startup let an agent choose a gene therapy and successfully inject the treatment, offering a startling glimpse of the future of research labs.
An AI Agent Injected Drugs Into a Live Mouse’s Brain
Source: Wired
Original reporting
Wired: read the full reportRelated stories
Wired
Meta’s Muse Could Upend All Kinds of Businesses. It Hasn’t Yet
Companies have spent the past several weeks trying to reassure investors that Muse and other AI agents pose more of an opportunity than a threat.
TechCrunch
Pile-ins, payouts, and pacing pressure: the investors behind the VCs open up
The money behind the money is thrilled, mostly.
TechCrunch
Nvidia weighs playing the cosigner for Nscale’s AI data center in West Virginia
When investors get nervous about AI spending, it helps to have the chipmaker that sells the chips offer to cosign the loan.
Ars Technica
Once again, NASA is asking for ideas to rescue Hubble from certain death
The space agency solicited ideas for reboosting Hubble four years ago, but they didn't go anywhere.
TechCrunch
Salesforce’s M A spree continues with a reported $375M deal for defense tech startup Rune
The AI logistics startup will bolster the CRM giant's Missionforce defense platform.
TechCrunch
Ollie, a privacy-focused AI assistant, is shutting down
As an increasing number of AI assistants flood the market, the founder of Ollie, an assistant that respected its users' privacy, says it will be shutting down in a week.